Total: £ 56.28
Published Date: 2025-08-08 | Pages: 79 | Tables: 76 | Pharma & Healthcare
The global Diabetes Stem Cell Therapy market size was US$ 127 million in 2024 and is forecast to a readjusted size of US$ 3180 million by 2031 with a CAGR of 59.3% during the forecast period 2025-2031.
North America key players of Diabetes Stem Cell Therapy include CellTrans, Seraxi, Vertex Pharmaceuticals, CRISPR Therapeutics, iTolerance, etc. The top five players hold a share about 100%.
The global Diabetes Stem Cell Therapy market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Seraxi
Vertex Pharmaceuticals
CRISPR Therapeutics
iTolerance
Sernova
Eli Lilly
CellTrans
By Type: (Dominant Segment vs High-Margin Innovation)
Preclinical
Clinical Phase
By Application: (Core Demand Driver vs Emerging Opportunity)
Type 1 Diabetes
Type 2 Diabetes
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Seraxi in Europe)
- Emerging Product Trends: Preclinical adoption vs. Clinical Phase premiumization
- Demand-Side Dynamics: Type 1 Diabetes growth in China vs. Type 2 Diabetes potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
(Additional regions can be customized based on client needs.)
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Diabetes Stem Cell Therapy market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Clinical Phase in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Type 2 Diabetes in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Diabetes Stem Cell Therapy value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Preclinical
1.2.3 Clinical Phase
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Type 1 Diabetes
1.3.3 Type 2 Diabetes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Diabetes Stem Cell Therapy Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Diabetes Stem Cell Therapy Revenue Market Share by Region (2020-2025)
2.4 Global Diabetes Stem Cell Therapy Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Diabetes Stem Cell Therapy Market Size and Prospective (2020-2031)
2.5.2 Europe Diabetes Stem Cell Therapy Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Diabetes Stem Cell Therapy Historic Market Size by Type (2020-2025)
3.2 Global Diabetes Stem Cell Therapy Forecasted Market Size by Type (2026-2031)
3.3 Different Types Diabetes Stem Cell Therapy Representative Players
4 Breakdown Data by Application
4.1 Global Diabetes Stem Cell Therapy Historic Market Size by Application (2020-2025)
4.2 Global Diabetes Stem Cell Therapy Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Diabetes Stem Cell Therapy Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Diabetes Stem Cell Therapy Players by Revenue (2020-2025)
5.1.2 Global Diabetes Stem Cell Therapy Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Diabetes Stem Cell Therapy Revenue
5.4 Global Diabetes Stem Cell Therapy Market Concentration Analysis
5.4.1 Global Diabetes Stem Cell Therapy Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Diabetes Stem Cell Therapy Revenue in 2024
5.5 Global Key Players of Diabetes Stem Cell Therapy Head office and Area Served
5.6 Global Key Players of Diabetes Stem Cell Therapy, Product and Application
5.7 Global Key Players of Diabetes Stem Cell Therapy, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Diabetes Stem Cell Therapy Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Diabetes Stem Cell Therapy Market Size by Type (2020-2025)
6.1.2.2 North America Diabetes Stem Cell Therapy Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Diabetes Stem Cell Therapy Market Size by Application (2020-2025)
6.1.3.2 North America Diabetes Stem Cell Therapy Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Diabetes Stem Cell Therapy Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Diabetes Stem Cell Therapy Market Size by Type (2020-2025)
6.2.2.2 Europe Diabetes Stem Cell Therapy Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Diabetes Stem Cell Therapy Market Size by Application (2020-2025)
6.2.3.2 Europe Diabetes Stem Cell Therapy Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
7 Key Players Profiles
7.1 Seraxi
7.1.1 Seraxi Company Details
7.1.2 Seraxi Business Overview
7.1.3 Seraxi Diabetes Stem Cell Therapy Introduction
7.1.4 Seraxi Revenue in Diabetes Stem Cell Therapy Business (2020-2025)
7.1.5 Seraxi Recent Development
7.2 Vertex Pharmaceuticals
7.2.1 Vertex Pharmaceuticals Company Details
7.2.2 Vertex Pharmaceuticals Business Overview
7.2.3 Vertex Pharmaceuticals Diabetes Stem Cell Therapy Introduction
7.2.4 Vertex Pharmaceuticals Revenue in Diabetes Stem Cell Therapy Business (2020-2025)
7.2.5 Vertex Pharmaceuticals Recent Development
7.3 CRISPR Therapeutics
7.3.1 CRISPR Therapeutics Company Details
7.3.2 CRISPR Therapeutics Business Overview
7.3.3 CRISPR Therapeutics Diabetes Stem Cell Therapy Introduction
7.3.4 CRISPR Therapeutics Revenue in Diabetes Stem Cell Therapy Business (2020-2025)
7.3.5 CRISPR Therapeutics Recent Development
7.4 iTolerance
7.4.1 iTolerance Company Details
7.4.2 iTolerance Business Overview
7.4.3 iTolerance Diabetes Stem Cell Therapy Introduction
7.4.4 iTolerance Revenue in Diabetes Stem Cell Therapy Business (2020-2025)
7.4.5 iTolerance Recent Development
7.5 Sernova
7.5.1 Sernova Company Details
7.5.2 Sernova Business Overview
7.5.3 Sernova Diabetes Stem Cell Therapy Introduction
7.5.4 Sernova Revenue in Diabetes Stem Cell Therapy Business (2020-2025)
7.5.5 Sernova Recent Development
7.6 Eli Lilly
7.6.1 Eli Lilly Company Details
7.6.2 Eli Lilly Business Overview
7.6.3 Eli Lilly Diabetes Stem Cell Therapy Introduction
7.6.4 Eli Lilly Revenue in Diabetes Stem Cell Therapy Business (2020-2025)
7.6.5 Eli Lilly Recent Development
7.7 CellTrans
7.7.1 CellTrans Company Details
7.7.2 CellTrans Business Overview
7.7.3 CellTrans Diabetes Stem Cell Therapy Introduction
7.7.4 CellTrans Revenue in Diabetes Stem Cell Therapy Business (2020-2025)
7.7.5 CellTrans Recent Development
8 Diabetes Stem Cell Therapy Market Dynamics
8.1 Diabetes Stem Cell Therapy Industry Trends
8.2 Diabetes Stem Cell Therapy Market Drivers
8.3 Diabetes Stem Cell Therapy Market Challenges
8.4 Diabetes Stem Cell Therapy Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Global Diabetes Stem Cell Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Diabetes Stem Cell Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Diabetes Stem Cell Therapy Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Diabetes Stem Cell Therapy Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Diabetes Stem Cell Therapy Revenue Share by Region (2020-2025)
Table 6. Global Diabetes Stem Cell Therapy Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Diabetes Stem Cell Therapy Revenue Share Forecast by Region (2026-2031)
Table 8. Global Diabetes Stem Cell Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Diabetes Stem Cell Therapy Revenue Market Share by Type (2020-2025)
Table 10. Global Diabetes Stem Cell Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Diabetes Stem Cell Therapy Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Diabetes Stem Cell Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Diabetes Stem Cell Therapy Revenue Market Share by Application (2020-2025)
Table 15. Global Diabetes Stem Cell Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Diabetes Stem Cell Therapy Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Diabetes Stem Cell Therapy Application
Table 18. Global Diabetes Stem Cell Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Diabetes Stem Cell Therapy Market Share by Players (2020-2025)
Table 20. Global Top Diabetes Stem Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Stem Cell Therapy as of 2024)
Table 21. Ranking of Global Top Diabetes Stem Cell Therapy Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Diabetes Stem Cell Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Diabetes Stem Cell Therapy, Headquarters and Area Served
Table 24. Global Key Players of Diabetes Stem Cell Therapy, Product and Application
Table 25. Global Key Players of Diabetes Stem Cell Therapy, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Diabetes Stem Cell Therapy Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Diabetes Stem Cell Therapy Revenue Market Share by Company (2020-2025)
Table 29. North America Diabetes Stem Cell Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Diabetes Stem Cell Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Diabetes Stem Cell Therapy Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Diabetes Stem Cell Therapy Revenue Market Share by Company (2020-2025)
Table 33. Europe Diabetes Stem Cell Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Diabetes Stem Cell Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 35. Seraxi Company Details
Table 36. Seraxi Business Overview
Table 37. Seraxi Diabetes Stem Cell Therapy Product
Table 38. Seraxi Revenue in Diabetes Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 39. Seraxi Recent Development
Table 40. Vertex Pharmaceuticals Company Details
Table 41. Vertex Pharmaceuticals Business Overview
Table 42. Vertex Pharmaceuticals Diabetes Stem Cell Therapy Product
Table 43. Vertex Pharmaceuticals Revenue in Diabetes Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 44. Vertex Pharmaceuticals Recent Development
Table 45. CRISPR Therapeutics Company Details
Table 46. CRISPR Therapeutics Business Overview
Table 47. CRISPR Therapeutics Diabetes Stem Cell Therapy Product
Table 48. CRISPR Therapeutics Revenue in Diabetes Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 49. CRISPR Therapeutics Recent Development
Table 50. iTolerance Company Details
Table 51. iTolerance Business Overview
Table 52. iTolerance Diabetes Stem Cell Therapy Product
Table 53. iTolerance Revenue in Diabetes Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 54. iTolerance Recent Development
Table 55. Sernova Company Details
Table 56. Sernova Business Overview
Table 57. Sernova Diabetes Stem Cell Therapy Product
Table 58. Sernova Revenue in Diabetes Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 59. Sernova Recent Development
Table 60. Eli Lilly Company Details
Table 61. Eli Lilly Business Overview
Table 62. Eli Lilly Diabetes Stem Cell Therapy Product
Table 63. Eli Lilly Revenue in Diabetes Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 64. Eli Lilly Recent Development
Table 65. CellTrans Company Details
Table 66. CellTrans Business Overview
Table 67. CellTrans Diabetes Stem Cell Therapy Product
Table 68. CellTrans Revenue in Diabetes Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 69. CellTrans Recent Development
Table 70. Diabetes Stem Cell Therapy Market Trends
Table 71. Diabetes Stem Cell Therapy Market Drivers
Table 72. Diabetes Stem Cell Therapy Market Challenges
Table 73. Diabetes Stem Cell Therapy Market Restraints
Table 74. Research Programs/Design for This Report
Table 75. Key Data Information from Secondary Sources
Table 76. Key Data Information from Primary Sources
List of Figures
Figure 1. Diabetes Stem Cell Therapy Product Picture
Figure 2. Global Diabetes Stem Cell Therapy Market Share by Type: 2024 VS 2031
Figure 3. Preclinical Features
Figure 4. Clinical Phase Features
Figure 5. Global Diabetes Stem Cell Therapy Market Share by Application: 2024 VS 2031
Figure 6. Type 1 Diabetes
Figure 7. Type 2 Diabetes
Figure 8. Diabetes Stem Cell Therapy Report Years Considered
Figure 9. Global Diabetes Stem Cell Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 10. Global Diabetes Stem Cell Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Diabetes Stem Cell Therapy Revenue Market Share by Region: 2020 VS 2024
Figure 12. North America Diabetes Stem Cell Therapy Revenue (US$ Million) Growth Rate (2020-2031)
Figure 13. Europe Diabetes Stem Cell Therapy Revenue (US$ Million) Growth Rate (2020-2031)
Figure 14. Global Diabetes Stem Cell Therapy Market Share by Players in 2024
Figure 15. Global Top Diabetes Stem Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Stem Cell Therapy as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by Diabetes Stem Cell Therapy Revenue in 2024
Figure 17. North America Diabetes Stem Cell Therapy Market Share by Type (2020-2025)
Figure 18. North America Diabetes Stem Cell Therapy Market Share by Application (2020-2025)
Figure 19. Europe Diabetes Stem Cell Therapy Market Share by Type (2020-2025)
Figure 20. Europe Diabetes Stem Cell Therapy Market Share by Application (2020-2025)
Figure 21. Seraxi Revenue Growth Rate in Diabetes Stem Cell Therapy Business (2020-2025)
Figure 22. Vertex Pharmaceuticals Revenue Growth Rate in Diabetes Stem Cell Therapy Business (2020-2025)
Figure 23. CRISPR Therapeutics Revenue Growth Rate in Diabetes Stem Cell Therapy Business (2020-2025)
Figure 24. iTolerance Revenue Growth Rate in Diabetes Stem Cell Therapy Business (2020-2025)
Figure 25. Sernova Revenue Growth Rate in Diabetes Stem Cell Therapy Business (2020-2025)
Figure 26. Eli Lilly Revenue Growth Rate in Diabetes Stem Cell Therapy Business (2020-2025)
Figure 27. CellTrans Revenue Growth Rate in Diabetes Stem Cell Therapy Business (2020-2025)
Figure 28. Bottom-up and Top-down Approaches for This Report
Figure 29. Data Triangulation
Figure 30. Key Executives Interviewed